Adult T-cell leukemia-derived factor/thioredoxin, produced by both human T-lymphotropic virus type I- and Epstein-Barr virus-transformed lymphocytes, acts as an autocrine growth factor and synergizes with interleukin 1 and interleukin 2.
Open accessThe DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
Abstract
Interleukin 1 (IL-1) has been obtained from the Epstein-Barr virus-infected B-lymphoblastoid cell line 3B6 and shown to be involved in autocrine growth of 3B6 B cells. Independently, adult T-cell leukemia-derived factor (ADF) was purified from human T-lymphotropic virus I-infected leukemic T-cell line (ATL-2) and reported as an interleukin 2 (IL-2) receptor-inducing factor. We have previously reported the same molecular mass, pI, and NH2-terminal amino acid sequence for both 3B6-derived IL-1 and ADF. cDNA cloning of ADF demonstrated high homology with the prokaryotic disulfide reducing enzyme thioredoxin. We show here that ADF and 3B6-derived IL-1 are identical. By RNA blot, 3B6 and ATL-2 cells were shown to contain high levels of 0.6-kilobase mRNA corresponding to ADF. Such message was not detected in resting peripheral blood lymphocytes but could be weakly induced by lymphocyte activation. Antibodies have been raised against synthetic peptides corresponding to the NH2 terminus and the COOH terminus of ADF. Immunoblotting and sequential immunoprecipitation with these antibodies revealed the same 13-kDa protein in 3B6 and ATL-2 cells. Recombinant ADF could sustain growth of 3B6 and ATL-2 cells at low cellular concentration without fetal calf serum; ADF, thus, appears involved in their autocrine growth. Similarly, recombinant ADF could enhance growth of other B-cell lines, including the Epstein-Barr virus-negative Burkitt lymphoma line BL41 and the lymphoblastoid cell lines CRAG8, CRB95, and 1G8. Finally, recombinant ADF exhibits marked synergism with other cytokines, such as IL-1 and IL-2, allowing virally infected lymphocytes to respond to suboptimal amounts of a variety of growth factors.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Holmgren, A. (1985) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.54.070185.001321 · Cited by 1,951
Uchiyama, T., Broder, S., & Waldmann, T. A. (1981) · The Journal of Immunology · doi:10.4049/jimmunol.126.4.1393 · Cited by 1,329
Tagaya, Y., Maeda, Y., Mitsui, A., Kondo, N., Matsui, H., Hamuro, J., Brown, N., Arai, K., Yokota, T., & Wakasugi, H. (1989) · The EMBO Journal · doi:10.1002/j.1460-2075.1989.tb03436.x · Cited by 562
Self-citationExpression of interleukin 2 receptors on activated human B cells.
Waldmann, T. A., Goldman, C. K., Robb, R. J., Depper, J. M., Leonard, W. J., Sharrow, S. O., Bongiovanni, K. F., Korsmeyer, S. J., & Greene, W. C. (1984) · The Journal of experimental medicine · doi:10.1084/jem.160.5.1450 · Cited by 482
Maruyama, M., Shibuya, H., Harada, H., Hatakeyama, M., Seiki, M., Fujita, T., Inoue, J.-I., Yoshida, M., & Taniguchi, T. (1987) · Cell · doi:10.1016/0092-8674(87)90437-5 · Cited by 425
Yodoi, J., Teshigawara, K., Nikaido, T., Fukui, K., Noma, T., Honjo, T., Takigawa, M., Sasaki, M., Minato, N., Tsudo, M., et al. (1985) · The Journal of Immunology · doi:10.4049/jimmunol.134.3.1623 · Cited by 367
Self-citationHolmgren, A. (1979) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)86818-7 · Cited by 323
Evidence that the endogenous heat-stable glucocorticoid receptor-activating factor is thioredoxin.
Grippo, J. F., Tienrungroj, W., Dahmer, M. K., Housley, P. R., & Pratt, W. B. (1983) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)43967-6 · Cited by 306
Escherichia coli thioredoxin: a subunit of bacteriophage T7 DNA polymerase.
Mark, D. F., & Richardson, C. C. (1976) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.73.3.780 · Cited by 272
Bennett, C. F., Balcarek, J. M., Varrichio, A., & Crooke, S. T. (1988) · Nature · doi:10.1038/334268a0 · Cited by 255
Cited by
Nordberg, J., & Arnér, E. S. J. (2001) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(01)00724-9 · Cited by 2,662
Physiological functions of thioredoxin and thioredoxin reductase
Arnér, E. S. J., & Holmgren, A. (2000) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.2000.01701.x · Cited by 2,525
The thioredoxin antioxidant system
Lu, J., & Holmgren, A. (2014) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2013.07.036 · Cited by 2,055
The Role of Oxidative Stress in Carcinogenesis
Klaunig, J. E., & Kamendulis, L. M. (2004) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.44.101802.121851 · Cited by 1,533
REDOX REGULATION OF CELLULAR ACTIVATION
Nakamura, H., Nakamura, K., & Yodoi, J. (1997) · Annual Review of Immunology · doi:10.1146/annurev.immunol.15.1.351 · Cited by 1,106
Self-citationRedox activation of Fos-Jun DNA binding activity is mediated by a DNA repair enzyme.
Xanthoudakis, S., Miao, G., Wang, F., Pan, Y. C., & Curran, T. (1992) · The EMBO Journal · doi:10.1002/j.1460-2075.1992.tb05411.x · Cited by 913
AP-1 transcriptional activity is regulated by a direct association between thioredoxin and Ref-1
Hirota, K., Matsui, M., Iwata, S., Nishiyama, A., Mori, K., & Yodoi, J. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.8.3633 · Cited by 843
Self-citationMatthews, J. R., Wakasugi, N., virelizier, J.-L., Yodoi, J., & Hay, R. T. (1992) · Nucleic Acids Research · doi:10.1093/nar/20.15.3821 · Cited by 831
Self-citationNishiyama, A., Matsui, M., Iwata, S., Hirota, K., Masutani, H., Nakamura, H., Takagi, Y., Sono, H., Gon, Y., & Yodoi, J. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.31.21645 · Cited by 730
Self-citationXanthoudakis, S., & Curran, T. (1992) · The EMBO Journal · doi:10.1002/j.1460-2075.1992.tb05097.x · Cited by 708
Hanschmann, E.-M., Godoy, J. R., Berndt, C., Hudemann, C., & Lillig, C. H. (2013) · Antioxidants & Redox Signaling · doi:10.1089/ars.2012.4599 · Cited by 677
Modulation of transcription factor NF-kappa B binding activity by oxidation-reduction in vitro.
Toledano, M. B., & Leonard, W. J. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.10.4328 · Cited by 657
Inside, outside, upside down: damage-associated molecular-pattern molecules (DAMPs) and redox
Rubartelli, A., & Lotze, M. T. (2007) · Trends in Immunology · doi:10.1016/j.it.2007.08.004 · Cited by 614
The thioredoxin system in cancer
Arnér, E. S. J., & Holmgren, A. (2006) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2006.10.009 · Cited by 589
Redox regulation of the immune response
Morris, G., Gevezova, M., Sarafian, V., & Maes, M. (2022) · Cellular & Molecular Immunology · doi:10.1038/s41423-022-00902-0 · Cited by 575
Human Placenta Thioredoxin Reductase
Gromer, S., Arscott, L. D., Williams, C. H., Schirmer, R. H., & Becker, K. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.32.20096 · Cited by 536
Vitamin D3 Up-Regulated Protein 1 Mediates Oxidative Stress Via Suppressing the Thioredoxin Function
Junn, E., Han, S. H., Im, J. Y., Yang, Y., Cho, E. W., Um, H. D., Kim, D. K., Lee, K. W., Han, P. L., Rhee, S. G., et al. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.12.6287 · Cited by 485
The thioredoxin system—From science to clinic
Gromer, S., Urig, S., & Becker, K. (2004) · Medicinal Research Reviews · doi:10.1002/med.10051 · Cited by 479
Secretion of thioredoxin by normal and neoplastic cells through a leaderless secretory pathway.
Rubartelli, A., Bajetto, A., Allavena, G., Wollman, E., & Sitia, R. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)35742-9 · Cited by 459
Properties and Biological Activities of Thioredoxins
Powis, G., & Montfort, W. R. (2001) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.41.1.261 · Cited by 451
The role of the redox protein thioredoxin in cell growth and cancer
Powis, G., Mustacich, D., & Coon, A. (2000) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(00)00313-0 · Cited by 443
Identification and characterization of rod-derived cone viability factor
Léveillard, T., Mohand-Saïd, S., Lorentz, O., Hicks, D., Fintz, A.-C., Clérin, E., Simonutti, M., Forster, V., Cavusoglu, N., Chalmel, F., et al. (2004) · Nature Genetics · doi:10.1038/ng1386 · Cited by 438
Holmgren, A. (1995) · Structure · doi:10.1016/s0969-2126(01)00153-8 · Cited by 436
Cloning and Expression of a Novel Mammalian Thioredoxin
Spyrou, G., Enmark, E., Miranda-Vizuete, A., & Gustafsson, J.-Å. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.5.2936 · Cited by 397
Thioredoxin reductase as a pathophysiological factor and drug target
Becker, K., Gromer, S., Schirmer, R. H., & Müller, S. (2000) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.2000.01703.x · Cited by 388
EXTRACELLULAR THIOLS AND THIOL/DISULFIDE REDOX IN METABOLISM
Moriarty-Craige, S. E., & Jones, D. P. (2004) · Annual Review of Nutrition · doi:10.1146/annurev.nutr.24.012003.132208 · Cited by 388
Angelini, G., Gardella, S., Ardy, M., Ciriolo, M. R., Filomeni, G., Di Trapani, G., Clarke, F., Sitia, R., & Rubartelli, A. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.022630299 · Cited by 371
Redox Signaling and the Emerging Therapeutic Potential of Thiol Antioxidants
Sen, C. K. (1998) · Biochemical Pharmacology · doi:10.1016/s0006-2952(97)00672-2 · Cited by 358
Cell signalling and the glutathione redox system
Filomeni, G., Rotilio, G., & Ciriolo, M. R. (2002) · Biochemical Pharmacology · doi:10.1016/s0006-2952(02)01176-0 · Cited by 357
Bertini, R., Zack Howard, O. M., Dong, H.-F., Oppenheim, J. J., Bizzarri, C., Sergi, R., Caselli, G., Pagliei, S., Romines, B., Wilshire, J. A., et al. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.189.11.1783 · Cited by 337
Self-citationProperties and Biological Activities of Thioredoxins
Powis, G., & Montfort, W. R. (2001) · Annual Review of Biophysics and Biomolecular Structure · doi:10.1146/annurev.biophys.30.1.421 · Cited by 336
Takebe, G., Yarimizu, J., Saito, Y., Hayashi, T., Nakamura, H., Yodoi, J., Nagasawa, S., & Takahashi, K. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m202773200 · Cited by 317
Self-citationThe Thioredoxin System as a Therapeutic Target in Human Health and Disease
Mahmood, D. F. D., Abderrazak, A., El Hadri, K., Simmet, T., & Rouis, M. (2013) · Antioxidants & Redox Signaling · doi:10.1089/ars.2012.4757 · Cited by 305
Lee, S.-R., Kim, J.-R., Kwon, K.-S., Yoon, H. W., Levine, R. L., Ginsburg, A., & Rhee, S. G. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.8.4722 · Cited by 274
GALTER, D., MIHM, S., & DRÖGE, W. (1994) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1994.tb18776.x · Cited by 274
Inhibition of endogenous thioredoxin in the heart increases oxidative stress and cardiac hypertrophy
Yamamoto, M., Yang, G., Hong, C., Liu, J., Holle, E., Yu, X., Wagner, T., Vatner, S. F., & Sadoshima, J. (2003) · Journal of Clinical Investigation · doi:10.1172/jci17700 · Cited by 274
Redox signalling and the control of cell growth and death
Powis, G., Briehl, M., & Oblong, J. (1995) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(95)02004-7 · Cited by 256
Redox-Sensing Release of Human Thioredoxin from T Lymphocytes with Negative Feedback Loops
Kondo, N., Ishii, Y., Kwon, Y.-W., Tanito, M., Horita, H., Nishinaka, Y., Nakamura, H., & Yodoi, J. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.1.442 · Cited by 116
Self-citationGriffiths, H. R. (2005) · Redox Report · doi:10.1179/135100005x83680 · Cited by 103
Metadata
- Authors
- Wakasugi, N., Tagaya, Y., Wakasugi, H., Mitsui, A., Maeda, M., Yodoi, J., & Tursz, T.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 1990-11
- Volume
- 87
- Issue
- 21
- Pages
- 8282-8286
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W1978029697
- Cited by
- 282
- References
- 21
- FWCI
- 4.91
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.